{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:10:58Z","timestamp":1792782658432,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Chung Hsing University","id":[{"id":"https:\/\/ror.org\/05vn3ca78","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-026-01487-w","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:18:29Z","timestamp":1771345109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual Osteoprotective Actions of the Kefir Peptide KFP-1: Enhancement of Bone Formation and Suppression of Bone Resorption in Cells and Murine Models"],"prefix":"10.1007","volume":"117","author":[{"given":"Min-Che","family":"Tung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary Ro-Lin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Yu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hueng-Chuen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ching","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkadir","family":"Cidem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.-Chien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2461-9150","authenticated-orcid":false,"given":"Chuan-Mu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"1487_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-021-02772-0","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S et al (2021) The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 16:609","journal-title":"J Orthop Surg Res"},{"key":"1487_CR2","first-page":"3557","volume":"25","author":"W Tanski","year":"2021","unstructured":"Tanski W, Kosiorowska J, Szymanska-Chabowska A (2021) Osteoporosis - risk factors, pharmaceutical and non-pharmaceutical treatment. Eur Rev Med Pharmacol Sci 25:3557\u20133566","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1487_CR3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393:364\u2013376","journal-title":"Lancet"},{"key":"1487_CR4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.intimp.2016.04.024","volume":"36","author":"J An","year":"2016","unstructured":"An J, Hao D, Zhang Q, Chen B, Zhang R, Wang Y et al (2016) Natural products for treatment of bone erosive diseases: the effects and mechanisms on inhibiting osteoclastogenesis and bone resorption. Int Immunopharmacol 36:118\u2013131","journal-title":"Int Immunopharmacol"},{"key":"1487_CR5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jn\/126.1.86","volume":"126","author":"H Tsuchita","year":"1996","unstructured":"Tsuchita H, Goto T, Shimizu T, Yonehara Y, Kuwata T (1996) Dietary casein phosphopeptides prevent bone loss in aged ovariectomized rats. J Nutr 126:86\u201393","journal-title":"J Nutr"},{"key":"1487_CR6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.lfs.2004.04.011","volume":"75","author":"M Narva","year":"2004","unstructured":"Narva M, Halleen J, Vaananen K, Korpela R (2004) Effects of Lactobacillus helveticus fermented milk on bone cells in vitro. Life Sci 75:1727\u20131734","journal-title":"Life Sci"},{"key":"1487_CR7","first-page":"852","volume":"106","author":"NK Lee","year":"2005","unstructured":"Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS et al (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852\u2013859","journal-title":"Blood"},{"key":"1487_CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15216540601156188","volume":"59","author":"M Arai","year":"2007","unstructured":"Arai M, Shibata Y, Pugdee K, Abiko Y, Ogata Y (2007) Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life 59:27\u201333","journal-title":"IUBMB Life"},{"key":"1487_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00394-016-1346-2","volume":"57","author":"S Reddi","year":"2018","unstructured":"Reddi S, Shanmugam VP, Tanedjeu KS, Kapila S, Kapila R (2018) Effect of buffalo casein-derived novel bioactive peptides on osteoblast differentiation. Eur J Nutr 57:593\u2013605","journal-title":"Eur J Nutr"},{"key":"1487_CR10","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s00217-016-2710-4","volume":"242","author":"S Reddi","year":"2016","unstructured":"Reddi S, Shanmugam VP, Kapila S, Kapila R (2016) Identification of buffalo casein-derived bioactive peptides with osteoblast proliferation activity. Eur Food Res Technol 242:2139\u20132146","journal-title":"Eur Food Res Technol"},{"key":"1487_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jnutbio.2016.08.003","volume":"38","author":"S Reddi","year":"2016","unstructured":"Reddi S, Kumar N, Vij R, Mada SB, Kapila S, Kapila R (2016) Akt drives buffalo casein-derived novel peptide-mediated osteoblast differentiation. J Nutr Biochem 38:134\u2013144","journal-title":"J Nutr Biochem"},{"key":"1487_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2017.11.004","volume":"99","author":"M Pandey","year":"2018","unstructured":"Pandey M, Kapila R, Kapila S (2018) Osteoanabolic activity of whey-derived anti-oxidative (MHIRL and YVEEL) and angiotensin-converting enzyme inhibitory (YLLF, ALPMHIR, IPA and WLAHK) bioactive peptides. Peptides 99:1\u20137","journal-title":"Peptides"},{"key":"1487_CR13","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1039\/C8FO00620B","volume":"9","author":"M Pandey","year":"2018","unstructured":"Pandey M, Kapila S, Kapila R, Trivedi R, Karvande A (2018) Evaluation of the osteoprotective potential of whey derived-antioxidative (YVEEL) and angiotensin-converting enzyme inhibitory (YLLF) bioactive peptides in ovariectomised rats. Food Funct 9:4791\u20134801","journal-title":"Food Funct"},{"key":"1487_CR14","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.3168\/jds.2019-17425","volume":"103","author":"P Shi","year":"2020","unstructured":"Shi P, Fan F, Chen H, Xu Z, Cheng S, Lu W et al (2020) A bovine lactoferrin-derived peptide induced osteogenesis via regulation of osteoblast proliferation and differentiation. J Dairy Sci 103:3950\u20133960","journal-title":"J Dairy Sci"},{"key":"1487_CR15","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1021\/acs.jafc.0c03385","volume":"68","author":"D Upadhyay","year":"2020","unstructured":"Upadhyay D, Kaur T, Kapila R, Kapila S (2020) Repertoire of structure-activity-based novel modified peptides elicits enhanced osteogenic potential. J Agric Food Chem 68:8308\u20138320","journal-title":"J Agric Food Chem"},{"key":"1487_CR16","doi-asserted-by":"crossref","DOI":"10.3390\/foods10061210","volume":"10","author":"NF Azizi","year":"2021","unstructured":"Azizi NF, Kumar MR, Yeap SK, Abdullah JO, Khalid M, Omar AR et al (2021) Kefir and its biological activities. Foods 10:1210","journal-title":"Foods"},{"key":"1487_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2016.49","volume":"6","author":"HL Chen","year":"2016","unstructured":"Chen HL, Tsai TC, Tsai YC, Liao JW, Yen CC, Chen CM (2016) Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway. Nutr Diabetes 6:e237","journal-title":"Nutr Diabetes"},{"key":"1487_CR18","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/ijo.2013.236","volume":"38","author":"HL Chen","year":"2014","unstructured":"Chen HL, Tung YT, Tsai CL, Lai CW, Lai ZL, Tsai HC et al (2014) Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob\/ob knockout mice. Int J Obes (Lond) 38:1172\u20131179","journal-title":"Int J Obes (Lond)"},{"key":"1487_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65782-8","volume":"10","author":"MC Tung","year":"2020","unstructured":"Tung MC, Lan YW, Li HH, Chen HL, Chen SY, Chen YH et al (2020) Kefir peptides alleviate high-fat diet-induced atherosclerosis by attenuating macrophage accumulation and oxidative stress in ApoE knockout mice. Sci Rep 10:8802","journal-title":"Sci Rep"},{"key":"1487_CR20","volume":"62","author":"YT Tung","year":"2018","unstructured":"Tung YT, Chen HL, Wu HS, Ho MH, Chong KY, Chen CM (2018) Kefir peptides prevent hyperlipidemia and obesity in high-fat-diet-induced obese rats via lipid metabolism modulation. Mol Nutr Food Res 62:1700505","journal-title":"Mol Nutr Food Res"},{"key":"1487_CR21","doi-asserted-by":"crossref","unstructured":"Chen HL, Hung KF, Yen CC, Laio CH, Wang JL, Lan YW et al. (2019) Kefir peptides alleviate particulate matter <4 mum (PM4.0)-induced pulmonary inflammation by inhibiting the NF-kappaB pathway using luciferase transgenic mice. Sci Rep, 9:11529.","DOI":"10.1038\/s41598-019-47872-4"},{"key":"1487_CR22","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.3168\/jds.2020-19222","volume":"104","author":"HL Chen","year":"2021","unstructured":"Chen HL, Lan YW, Tu MY, Tung YT, Chan MN, Wu HS et al (2021) Kefir peptides exhibit antidepressant-like activity in mice through the BDNF\/TrkB pathway. J Dairy Sci 104:6415\u20136430","journal-title":"J Dairy Sci"},{"key":"1487_CR23","volume":"12","author":"MY Tu","year":"2020","unstructured":"Tu MY, Han KY, Chang GR, Lai GD, Chang KY, Chen CF et al (2020) Kefir peptides prevent estrogen deficiency-induced bone loss and modulate the structure of the gut microbiota in ovariectomized mice. Nutrients 12:3432","journal-title":"Nutrients"},{"key":"1487_CR24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00198-014-2908-x","volume":"26","author":"HL Chen","year":"2015","unstructured":"Chen HL, Tung YT, Chuang CH, Tu MY, Tsai TC, Chang SY et al (2015) Kefir improves bone mass and microarchitecture in an ovariectomized rat model of postmenopausal osteoporosis. Osteoporosis Int 26:589\u2013599","journal-title":"Osteoporosis Int"},{"key":"1487_CR25","doi-asserted-by":"crossref","unstructured":"Yen C-C, Liu Y-W, Chang GR-L, Lan Y-W, Kao Y-T, Cheng S-N et al. (2022) Therapeutic effects of kefir peptides on hemophilia-induced osteoporosis in mice with deficient coagulation factor VIII. Front Cell Dev Biol, vol 10.","DOI":"10.3389\/fcell.2022.794198"},{"key":"1487_CR26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113859","volume":"156","author":"GR Chang","year":"2022","unstructured":"Chang GR, Lin WY, Fan HC, Tu MY, Liu YH, Yen CC et al (2022) Kefir peptides ameliorate osteoporosis in AKR1A1 knockout mice with vitamin C deficiency by promoting osteoblastogenesis and inhibiting osteoclastogenesis. Biomed Pharmacother 156:113859","journal-title":"Biomed Pharmacother"},{"key":"1487_CR27","volume":"10","author":"MY Tu","year":"2015","unstructured":"Tu MY, Chen HL, Tung YT, Kao CC, Hu FC, Chen CM (2015) Short-term effects of kefir-fermented milk consumption on bone mineral density and bone metabolism in a randomized clinical trial of osteoporotic patients. PLoS ONE 10:e0144231","journal-title":"PLoS ONE"},{"key":"1487_CR28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1158812","volume":"11","author":"GR Chang","year":"2023","unstructured":"Chang GR, Cheng WY, Fan HC, Chen HL, Lan YW, Chen MS et al (2023) Kefir peptides attenuate atherosclerotic vascular calcification and osteoporosis in atherogenic diet-fed ApoE (-\/-) knockout mice. Front Cell Dev Biol 11:1158812","journal-title":"Front Cell Dev Biol"},{"key":"1487_CR29","volume":"65","author":"GR Chang","year":"2021","unstructured":"Chang GR, Tu MY, Chen YH, Chang KY, Chen CF, Lai JC et al (2021) KFP-1, a novel calcium-binding peptide isolated from kefir, promotes calcium influx through TRPV6 channels. Mol Nutr Food Res 65:e2100182","journal-title":"Mol Nutr Food Res"},{"key":"1487_CR30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcb.20958","volume":"99","author":"T Komori","year":"2006","unstructured":"Komori T (2006) Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 99:1233\u20131239","journal-title":"J Cell Biochem"},{"key":"1487_CR31","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.2741\/2296","volume":"12","author":"W Huang","year":"2007","unstructured":"Huang W, Yang S, Shao J, Li YP (2007) Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 12:3068\u20133092","journal-title":"Front Biosci"},{"key":"1487_CR32","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1172\/JCI96221","volume":"128","author":"SY Lee","year":"2018","unstructured":"Lee SY, Long F (2018) Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation. J Clin Invest 128:5573\u20135586","journal-title":"J Clin Invest"},{"key":"1487_CR33","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/jcb.23094","volume":"112","author":"J Zhu","year":"2011","unstructured":"Zhu J, Shimizu E, Zhang X, Partridge NC, Qin L (2011) EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. J Cell Biochem 112:1749\u20131760","journal-title":"J Cell Biochem"},{"key":"1487_CR34","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.gendis.2022.07.011","volume":"10","author":"R Vlashi","year":"2023","unstructured":"Vlashi R, Zhang X, Wu M, Chen G (2023) Wnt signaling: essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders. Genes Dis 10:1291\u20131317","journal-title":"Genes Dis"},{"key":"1487_CR35","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1152\/physrev.00028.2017","volume":"98","author":"JW Lowery","year":"2018","unstructured":"Lowery JW, Rosen V (2018) The BMP pathway and its inhibitors in the skeleton. Physiol Rev 98:2431\u20132452","journal-title":"Physiol Rev"},{"key":"1487_CR36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2741\/3673","volume":"16","author":"N Takahashi","year":"2011","unstructured":"Takahashi N, Maeda K, Ishihara A, Uehara S, Kobayashi Y (2011) Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals. Front Biosci (Landmark Ed) 16:21\u201330","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1487_CR37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","volume":"21","author":"JH Kim","year":"2014","unstructured":"Kim JH, Kim N (2014) Regulation of NFATc1 in osteoclast differentiation. J Bone Metab 21:233\u2013241","journal-title":"J Bone Metab"},{"key":"1487_CR38","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.febslet.2009.06.047","volume":"583","author":"I Song","year":"2009","unstructured":"Song I, Kim JH, Kim K, Jin HM, Youn BU, Kim N (2009) Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 583:2435\u20132440","journal-title":"FEBS Lett"},{"key":"1487_CR39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gene.2009.06.013","volume":"446","author":"W Balkan","year":"2009","unstructured":"Balkan W, Martinez AF, Fernandez I, Rodriguez MA, Pang M, Troen BR (2009) Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand. Gene 446:90\u201398","journal-title":"Gene"},{"key":"1487_CR40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbaexp.2007.08.005","volume":"1769","author":"Z Shen","year":"2007","unstructured":"Shen Z, Crotti TN, Flannery MR, Matsuzaki K, Goldring SR, McHugh KP (2007) A novel promoter regulates calcitonin receptor gene expression in human osteoclasts. Biochim Biophys Acta 1769:659\u2013667","journal-title":"Biochim Biophys Acta"},{"key":"1487_CR41","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1359\/jbmr.070401","volume":"22","author":"M Yagi","year":"2007","unstructured":"Yagi M, Ninomiya K, Fujita N, Suzuki T, Iwasaki R, Morita K et al (2007) Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J Bone Miner Res 22:992\u20131001","journal-title":"J Bone Miner Res"},{"key":"1487_CR42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI200419657","volume":"114","author":"F Ikeda","year":"2004","unstructured":"Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV et al (2004) Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest 114:475\u2013484","journal-title":"J Clin Invest"},{"key":"1487_CR43","volume":"21","author":"JY Kang","year":"2020","unstructured":"Kang JY, Kang N, Yang YM, Hong JH, Shin DM (2020) The role of Ca(2+)-NFATc1 signaling and its modulation on osteoclastogenesis. Int J Mol Sci 21:3646","journal-title":"Int J Mol Sci"},{"key":"1487_CR44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194960","volume":"20","author":"M Yoneda","year":"2019","unstructured":"Yoneda M, Suzuki H, Hatano N, Nakano S, Muraki Y, Miyazawa K et al (2019) PIEZO1 and TRPV4, which are distinct mechano-sensors in the osteoblastic MC3T3-E1 cells, modify cell-proliferation. Int J Mol Sci 20:4960","journal-title":"Int J Mol Sci"},{"key":"1487_CR45","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1002\/jcp.27432","volume":"234","author":"B Cao","year":"2019","unstructured":"Cao B, Dai X, Wang W (2019) Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca(2+) -calcineurin-NFATc1 pathway. J Cell Physiol 234:6831\u20136841","journal-title":"J Cell Physiol"},{"key":"1487_CR46","doi-asserted-by":"crossref","first-page":"25354","DOI":"10.1074\/jbc.M109.075234","volume":"285","author":"E Chamoux","year":"2010","unstructured":"Chamoux E, Bisson M, Payet MD, Roux S (2010) TRPV-5 mediates a receptor activator of NF-kappaB (RANK) ligand-induced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption. J Biol Chem 285:25354\u201325362","journal-title":"J Biol Chem"},{"key":"1487_CR47","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1021\/jf5035256","volume":"62","author":"L Sanchez-Rivera","year":"2014","unstructured":"Sanchez-Rivera L, Ares I, Miralles B, Gomez-Ruiz JA, Recio I, Martinez-Larranaga MR et al (2014) Bioavailability and kinetics of the antihypertensive casein-derived peptide HLPLP in rats. J Agric Food Chem 62:11869\u201311875","journal-title":"J Agric Food Chem"},{"key":"1487_CR48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dmpk.2015.08.005","volume":"31","author":"R Gu","year":"2016","unstructured":"Gu R, He Y, Han S, Yuan S, An Y, Meng Z et al (2016) Pharmacokinetics and bioavailability of tuftsin-derived T peptide, a promising antitumor agent, in beagles. Drug Metab Pharmacokinet 31:51\u201356","journal-title":"Drug Metab Pharmacokinet"}],"updated-by":[{"DOI":"10.1007\/s00223-026-01589-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000}}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01487-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01487-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01487-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:26:11Z","timestamp":1792229171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01487-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1487"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01487-w","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The figures 1- 8 were published in wrong order. But the captions are correct. It has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00223-026-01589-5","URL":"https:\/\/doi.org\/10.1007\/s00223-026-01589-5","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Min-Che Tung, Gary Ro-Lin Chang, Min-Yu Tu, Hueng-Chuen Fan, Chih-Ching Yen, Abdulkadir Cidem, I-Chien Chen, and Chuan-Mu Chen declare that they have no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of National Chung Hsing University (IACUC No. 106\u2013131). Experimental protocols and animal care were provided according to the guideline for the care and use of animals established by National Chung Hsing University.","order":2,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32"}}